Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 45, 2019 - Issue 1
Submit an article Journal homepage
332
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Assessment of lisdexamfetamine dimesylate stability and identification of its degradation product by NMR spectroscopy

Graciela CarlosFaculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Correspondence[email protected]
View further author information
,
Alvicler MagalhãesInstituto de Química, Universidade Estadual de Campinas, Campinas, BrazilView further author information
,
Ana Cristina IslerInstituto de Química, Universidade Estadual de Campinas, Campinas, BrazilView further author information
,
Eloisa ComiranFaculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; View further author information
&
Pedro Eduardo FröehlichFaculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; View further author information
Pages 139-146 | Received 03 May 2018, Accepted 17 Sep 2018, Published online: 01 Nov 2018

References

  • Jain D, Basniwal PK. Forced degradation and impurity profiling: recent trends in analytical perspectives. J Pharm Biomed Anal. 2013;86:11–35.
  • Nageswara Rao R, Nagaraju V. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs. J Pharm Biomed Anal. 2003;33:335–377.
  • International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Impurities in New Drug Substances - Q3A(R2). Switzerland; 2006. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3A_R2/Step4/Q3A_R2__Guideline.pdf.
  • Smith RJ, Webb ML. Analysis of Drug Impurities. Vol 1. Wiley-Blackwell; 2007. doi:10.1002/9780470988749
  • Singh S, Handa T, Narayanam M, et al. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products. J Pharm Biomed Anal. 2012;69:148–173.
  • International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). International Conference on Harmonisation of Stability Testing of New Drug Substances and Products Q1A (R2). Geneva; 2003. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf
  • Singh S, Junwal M, Modhe G, et al. Trends in analytical chemistry Forced degradation studies to assess the stability of drugs and products. Trends Analyt Chem. 2013;49:71–88.
  • Yoshioka S, Stella VJ. Stability of Drugs and Dosage Forms. Boston: Kluwer Academic Publisher; 2002.
  • Rao RN, Raju AN, Narsimha R. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study. J Pharm Biomed Anal. 2008;46:505–519.
  • Mickle T, Krishnan S, Bishop B, et al. US 7, 105, 486 B2.; 2006.
  • Carlos G, Comiran E, de Oliveira MH, et al. Development, validation and comparison of two stability-indicating RP-LC methods using charged aerosol and UV detectors for analysis of lisdexamfetamine dimesylate in capsules. Arab J Chem. 2016;9:S1905–S1914.
  • Holzgrabe U, Wawer I, Diehl B. NMR Spectroscopy in Drug Development and Analysis. Vol 3. Weinheim: WILEY-VCH; 1999.
  • Maggio RM, Calvo NL, Vignaduzzo SE, et al. Pharmaceutical impurities and degradation products: Uses and applications of NMR techniques. J Pharm Biomed Anal. 2014;101:102–122.
  • Holzgrabe U. Quantitative NMR spectroscopy in pharmaceutical applications. Prog Nucl Magn Reson Spectrosc. 2010;57:229–240.
  • WHO. Expert Committee on Specifications for Pharmaceutical Preparations WHO Technical Report Series, No. 929, 39th Report. Geneva: WHO; 2005.
  • Clayden J, Greevs N, Warren S, et al. Organic Chemistry. Vol 2. New York: Oxford University Press; 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.